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1. Introduction 
Certain polycyclic aromatic hydrocarbons can be 
converted to carcinogenic derivatives during 
metabolism in animal tissue [ 1,2]. Identification of 
the carcinogenic derivatives and elucidation of the 
enzymatic pathways of their formation have been 
the focus of intensive study for a number of years 
[3-S]. A substantial body of recent evidence 
implicates bay region diolepoxides as likely candi- 
dates for the ultimate carcinogenic forms of a number of 
polycyclic aromatic hydrocarbons [6]. In the case of 
BP, 7,8-dial-9,10-epoxides have been found to be 
more mutagenic and carcinogenic than any of the 
other reported or suspected metabolites of the parent 
hydrocarbon [7-91. In vitro experiments have 
demonstrated that NADPH-dependent mixed-func- 
tion oxidases possessing cytochrome P-450 as the 
terminal oxidase will catalyze the oxidation of 
BP-7,8diol to BPDE [lo-121. 
We have reported that the addition of 20:4 to PES 
preparations from ram seminal vesicles causes the 
cooxidation of BP-7,8-diol to derivatives which are 
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strongly mutagenic to Salmonella typhimurium strain 
TA 98 [ 131. It has also been reported that PES 
preparations from guinea pig lung cooxidize BP-7,8- 
diol to derivatives which covalently bind to protein 
and nucleic acid [ 141. In neither study were the actual 
products of BP-7,8-diol metabolism identified. We 
report here the results of our study of the arachidonic 
acid-dependent metabolism of [14C]BP-7,8-diol which 
indicate that a diolepoxide is produced as an inter- 
mediate. We also present evidence that cytochrome 
P-450 plays no role in this cooxidation, which implies 
that enzyme systems besides the mixed-function 
oxidases can catalyze the terminal activation step in 
BP carcinogenesis. 
2. Materials and methods 
20:4 was generously provided by Dr John Paulsrud, 
Hoffman-LaRoche and was purified by open column 
chromatography on silicic acid. Unlabeled BP-7,8-diol, 
the syn and anti isomers of the diol-epoxides, and 
[‘4C]BP-7,8-diol were obtained from the National 
Cancer Institute Carcinogenesis Research Program. 
The [r4C]BP-7,8-diol was purified by reverse-phase 
HPLC immediately prior to use. Authentic standards 
of the BP-tetraols were prepared by hydrolysis of the 
syn and anti diolepoxides in 100 mM sodium 
phosphate (pH 7.8) followed by extraction and 
purification by HPLC. The structures were assigned 
by the correspondence of relative yield and HPLC 
mobility to [IO,1 11. 15HPETE was prepared 
according to [ 151. Ram seminal vesicle microsomes 
and the Tween-20 solubilized enzyme were prepared 
as in [16]. 
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Preparative scale metabolism of [r4C]BP-7,8-diol 
was carried out at 37°C in 200 ml of 100 mM sodium 
phosphate (pH 7.8) containing solubilized enzyme 
(110 mg protein) and 1 mg [r4C]BP-7,8-diol (8 yCi/ 
@mol). After a 3 mm preincubation, 9 mg 20:4 was 
added. The reaction was terminated after 15 min by 
the addition of 180 ml acetone and the products 
were extracted with 360 ml ethyl acetate. Following 
drying (MgSO,), the solvent was evaporated and the 
residue was taken up in 500 J.I~ ethyl acetate for 
HPLC analysis. 
The incubations described in table 1 were per- 
formed at 37% in 1 .O ml 100 mM TrisHCl (pH 7.4) 
containing microsomes (I mg protein), 15 I.tmol 
MgCla , and 20 nmol [14C]BP-7,8-diol (4.5 &i/&mol). 
After a 3 min preincubation, reaction was initiated by 
the addition of the appropriate substrate and allowed 
to proceed for 3 min. One series of experiments were 
performed with NADPH for 15 min. BHA (200 nmol) 
was added to terminate cooxidation and the incuba- 
tion mixtures were allowed to stand at 0°C for 
30 min to complete solvolysis of BPDE. After ethyl 
acetate xtraction, the samples were chromatographed 
on 20 cm silica gel 60 plates (EM labs) with chioro- 
form~ethanol(70f30, v/v). Radioactive zones were 
detected using a Berthold LB-2760 radiochromato- 
gram scanner and the percentage of radioactivity 
cochromatographing with authentic BP-tetraols 
determined by liquid scintillation counting. 
Optical difference-spectra of the solubilized 
enzyme preparation were performed on a Cary 118. 
Solub~lized enzyme (6.0 ml, 800 Erg protein~ml) was 
bubbled with CO for 2 min, divided between 
2 cuvettes, and a baseline spectrum was recorded. 
Solid Na&O,, was added to the sample cuvette, the 
contents were mixed, and the difference spectrum 
recorded. 
3. Results and discussion 
Figure 1 b is the HPLC profile of the radioactive 
products obtained when [‘4C]BP-7,8-diol isincubated 
with a solubilized PES preparation and 20:4. The 
major radioactive product (-70% of the total 
metabolism) cochromatographs with an authentic 
standard of the anti-trans-BP-tetraol prepared by 
hydrolysis of anti-BPDE. The ultraviolet spectrum of 
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Fig.1. FIPLC analysis ofthe products ofBP-7,8-diol xidation 
by ram seminal vesicles. Chromatography was performed on 
a column of Lichrosorb RP-18 (4 X 250 mm) using 45% 
methanol in water at 1.5 ml/m& (a) Ultraviolet profile of a 
mixture of authentic BP-tetraol standards; (b) radioactivity 
profile of the products of BP-7,&diol oxidation by PES and 
20:4; (c) same as(b) except a boiled enzyme preparation was 
used for the incubation. 
the major metabolite is identical to the dtraviolet 
spectrum of the acts-bugs-BP-te~aol nd is typical of 
a BP derivative with a fufiy saturated benzo ring. This 
indicates that metabolism of BP-7,8-diol has occurred 
at the 9,10-double bond. The high resolution mass 
spectrum of the major metabolite xhibits a molecular 
ion which is the base peak at m/e 320.1046 (calculated 
for C&H,,04, 320.1044) The remaining radioactive 
peaks in fig.1 b cochromatograph with the other known 
tetraol metabolites of BP, but we have been unable to 
obtain sufficient quantities of these compounds for 
complete spectral analysis. 
The chromatographic characteristics, ultraviolet 
spectrum, and mass ~ctrum of the major metabolite 
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Scheme 1 
of BP-7,8-diol indicate that it is the anti-trans-BP- 
tetraol. This compound is not mutagenic which 
suggests hat the mutagen produced uring the PES- 
dependent metabolism. of BP-7,8-diol is an inter- 
mediate which undergoes non-enzymatic conversion 
to the observed tetraol. The most likely possibility 
for the intermediate isthe anti-BPDE which is highly 
mutagenic and hydrolyzes pontaneously toa mixture 
of the tram and cis isomers of the tetraols (pre- 
dominantly trans) [ 10,ll ,17,18] (scheme 1). We 
cannot completely rule out the possibility that a 
highly mutagenic intermediate, distinct from BPDE, 
is produced which undergoes conversion to the same 
tetraol. However, we have no evidence for the for- 
mation of any intermediate besides BPDE. 
Previous tudies have shown that PES-dependent 
cooxidations are peroxidatic and utilize the hydro- 
peroxy endoperoxide, PGGs, as the hydroperoxide 
substrate [19]. Incubation of [14C]BP-7,8-diol with 
PES and 15HPETE, a model for PCGs, followed by 
HPLC analysis generates a chromatographic profile 
identical to fig.lb (data not shown). Equal amounts 
of 20:4 and 1%HPETE trigger equal amounts of 
BP-7,8-diol oxidation when incubated with intact 
microsomes (table 1). In contrast, IN-IPETE causes a
substantially higher level of diol oxidation than 20:4 
when added to boiled microsomes. This indicates that 
a significant non-enzymatic hydroperoxide-dependent 
oxidation occurs. This non-enzymatic component is 
also observed with BP as substrate and suggests hat a 
major role of PES in cooxidation is as a generator of 
lipid hydroperoxides [20]. 
The fact that the cooxidation is peroxidatic and 
partially enzymatic raises questions about the nature 
of the peroxidase. PES, purified to homogeneity, 
contains a reconstitutable peroxidase activity [21]. 
However, this may not be the sole peroxidase 
operative in crude enzyme preparations. In particular, 
one must consider the possible involvement of cyto- 
chrome P-450. Figure 2 is the dithionite reduced- 
Fig.2. Dithionite-reduced-carbon monoxide difference 
spectrum of the Tween-20 solubilized preparation from ram 
seminal vesicles. Procedure described in section 2. Protein 
was 800 pg/ml. 
Table 1 
Metabolism of BP-7,8diol by Ram seminal vesicle microsomes 
Additive Tetraolsa (pmol) 
Intact enzyme Boiled enzyme Net metabolismb 
None - ControlC 393 + 20 178 f 20 215 
1 mM NADPH 295 f 7 156 f 40 139 
1 mM NADPH (15 min) 348 f 80 137 * 16 211 
0.1 mM 20 : 4 551 f 25 233 * 16 318 
0.1 mM 20 : 4 + 0.1 mM indo 251 f 24 240 * 20 11 
0.1 mM 15-HPETE 554 * 110 412* 3 142 
a Unless indicated, all incubations were performed for 3 min. The results are expressed 
as total metabolism during the incubation period 
b Difference between intact enzyme and boiled enzyme columns 
c Incubation conditions are described in section 2 
15 
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carbon monoxide difference spectrum of the Tween-20 
solubilized PES from ram seminal vesicles. A peak at 
424 nm and a trough at 408 nm are evident. These 
spectral features may be related to the reduced and 
oxidized forms of PES reported [22]. Figure 2 con- 
tains no A4s0 band indicating that the cytochrome 
P-450 content of this preparation isbelow the limit 
of spectral detection. 
Since cytochrome P-450 is spectrally undetectable in
the solubilized preparation, we have attempted to 
detect it using the NADPH-dependent oxidation of 
BP-7,8-diol as an enzymatic assay. For these experi- 
ments, we used a microsomal enzyme in order to 
avoid possible complications introduced by the 
solubilization procedufe. The addition of 1 mM 
NADPH to ram seminal vesicle microsomes gives rise 
to no BP-7,8-diol oxidation above controls - in 
fact, there is slight inhibition (table 1). The addition 
of the mixed-function oxidase inhibitors, carbon 
monoxide (3 min bubbling) or metyrapone (1 mM) 
has no inhibitory effect on any of the incubations 
listed in table 1. In contrast, the PES inhibitor, indo- 
methacin, completely inhibits BP-7,8-diol oxidation 
in the presence of 20:4 or in its absence. The latter 
observation suggests hat the oxidation of BP-7,8-diol 
observed in the control incubations, performed in the 
absence of exogenous 20:4, is due to cooxidation 
triggered by endogenous 20:3 or 20:4 released from 
membrane lipids during the course of the incuba- 
tions. 
We have been unable to detect any NADPH- 
dependent activation of BP-7,8-diol to mutagenic 
derivatives in the presence of solubilized ram seminal 
vesicle nzyme preparations (Reed, G. A., unpublished 
observations). Therefore, spectral, metabolic, and 
mutagenicity experiments strongly suggest that 
cytocluome P-450 is not the peroxidase involved in 
the PES-dependent oxidation of BP-7,8-diol in the 
ram seminal vesicle. Work is in progress to determine 
if the peroxidase operative in crude enzyme prepara- 
tions is the hydroperoxidase component of PES. 
Regardless of the outcome of these experiments, the 
present work indicates that, in vitro, enzyme systems 
besides the mixed-function oxidases can catalyze the 
terminal activation step in benzo [alpyrene 
carcinogenesis. 
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